|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61K 47/26 | |||
| A61K 9/19 | |||
| C07K 16/18 |
| (11) | Patento numeris | 3016677 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14752412.8 |
| Europos patento paraiškos padavimo data | 2014-07-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-05-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-12-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2014/062806 |
| Data | 2014-07-03 |
| (87) | Numeris | WO 2015/001504 |
| Data | 2015-01-08 |
| (30) | Numeris | Data | Šalis |
| 201361843011 P | 2013-07-04 | US | |
| 201461979886 P | 2014-04-15 | US |
| (72) |
GARIDEL, Patrick, DE
LANGER, Andreas, DE
GRUNDMAN, Michael, US
|
| (73) |
Prothena Biosciences Limited,
Adelphi Plaza Upper George`s Street D n Laoghaire, Co. Dublin, A96 T927,
IE
|
| (54) | ANTIBODY FORMULATIONS AND METHODS |
| ANTIBODY FORMULATIONS AND METHODS |